AbbVie vs Twilio: Founders, CEOs and History
AbbVie was founded in 2013 by Abbott Laboratories (spin-off origin) and is led by Robert A. Michael. Twilio was founded in 2008 by Jeff Lawson, John Wolthuis, Evan Cooke and is led by Khozema Shipchandler.
Company facts
Founders
AbbVie
Abbott Laboratories (spin-off origin)
Abbott Laboratories was AbbVie's corporate predecessor. AbbVie's official launch materials describe the company as formed in 2013 following separation from Abbott. Richard A.
Twilio
Jeff Lawson
Jeff Lawson co-founded Twilio in 2008 and was CEO until January 2024, leading it through its 2016 IPO and the SendGrid and Segment acquisitions. He wrote Ask Your Developer (2021) about developer-led software.
John Wolthuis
John Wolthuis co-founded Twilio in 2008. He architected the initial telephony backend that allowed developers to send text messages and make phone calls using a simple web API.
Evan Cooke
Evan Cooke co-founded Twilio and served as its first CTO. He was instrumental in designing the company's highly reliable cloud architecture, ensuring the API could scale to handle massive, instantaneous spikes in SMS traffic (such as during Uber surges or Airb…
CEOs and their tenures
AbbVie
- Richard A. Gonzalez2013–2024
Founding Chairman and Chief Executive Officer
Served as AbbVie's chief executive officer from its formation in 2013 through June 2024 and as executive chairman through June 2025.
Source - Robert A. Michael2024–present
Chairman and Chief Executive Officer
Became chief executive officer on July 1, 2024 and chairman on July 1, 2025. He previously led finance, commercial operations, and corporate strategy roles at AbbVie.
Source
Twilio
- Jeff Lawson2008–2024
Co-founder and CEO
As the long-time CEO, he aggressively scaled the company into a $60 billion behemoth before intense pressure from activist investors forced him to resign in 2024 following growth stagnation.
Source - Aidan Viggiano2023–present
Chief Financial Officer
As CFO, she strictly enforces the new profitability mandates, cutting massive amounts of real estate and software expenses across the enterprise.
Source - Khozema Shipchandler2024–present
Chief Executive Officer
Taking over as CEO in 2024, he shifted the company's focus away from unprofitable hyper-growth toward heavily optimizing the highly lucrative core communications platform.
Source
Timeline: AbbVie and Twilio side by side
2008Twilio
Company Founded
Jeff Lawson, Evan Cooke, and John Wolthuis founded Twilio and launched its first voice API for developers.
2010Twilio
SMS API Launched
Twilio added programmable SMS, which became its largest product line.
2013AbbVie
AbbVie Launches as an Independent Company
AbbVie launched after Abbott Laboratories separated its research-based pharmaceutical business and began NYSE trading under ABBV.
2015AbbVie
Pharmacyclics Acquisition Completed
AbbVie completed its acquisition of Pharmacyclics, adding Imbruvica and expanding its hematologic oncology business.
2015Twilio
Authy Acquired
Twilio acquired the two-factor authentication company Authy in 2015.
2016Twilio
NYSE IPO
Twilio listed on the NYSE under the ticker TWLO in June 2016, pricing shares at $15.
2019AbbVie
Skyrizi Receives Initial U.S. Approval
The FDA approved Skyrizi for adults with moderate to severe plaque psoriasis in April 2019.
2019AbbVie
Rinvoq Receives Initial U.S. Approval
The FDA approved Rinvoq for adults with moderate to severe rheumatoid arthritis in August 2019.
2019Twilio
SendGrid Acquisition
Twilio completed its all-stock acquisition of email platform SendGrid, announced at about $2 billion.
2020AbbVie
Allergan Acquisition Completed
AbbVie completed the Allergan acquisition, adding neuroscience, eye care, and Allergan Aesthetics products including Botox and Juvederm.
2020Twilio
Segment Acquisition
Twilio acquired customer data platform Segment for about $3.2 billion, its largest deal.
2021Twilio
Revenue Passes $2.8 Billion
Twilio reported FY2021 revenue of $2.842 billion, up 61% year over year, with a net loss of $949.9 million.
2023AbbVie
U.S. Humira Biosimilar Competition Begins
Humira began facing U.S. biosimilar competition, and AbbVie reported a subsequent decline in Humira revenue.
2023Twilio
Restructuring
Twilio cut about 17% of its workforce in February 2023 and made further reductions later in the year as it shifted toward profitability.
2024AbbVie
ImmunoGen Acquisition Completed
AbbVie completed its acquisition of ImmunoGen, adding Elahere and antibody-drug conjugate programs.
2024AbbVie
Robert A. Michael Becomes CEO
Robert A. Michael succeeded Richard A. Gonzalez as chief executive officer effective July 1, 2024.
2024AbbVie
Cerevel Therapeutics Acquisition Completed
AbbVie completed its acquisition of Cerevel Therapeutics, adding clinical-stage neuroscience programs.
2024Twilio
CEO Transition
Co-founder Jeff Lawson stepped down as CEO in January 2024 and Khozema Shipchandler succeeded him.
2025AbbVie
Robert A. Michael Becomes Chairman
Robert A. Michael added the chairman role effective July 1, 2025, when Richard A. Gonzalez retired from the board.
2025AbbVie
FY2025 Revenue Reaches $61.160 Billion
AbbVie reported FY2025 net revenue of $61.160 billion and net income of $4.226 billion.
2025Twilio
First Full-Year GAAP Profit and Stytch Deal
Twilio reported FY2025 revenue of $5.067 billion and net income of $33.8 million, and completed its acquisition of identity platform Stytch on November 14, 2025.
2026AbbVie
Q1 2026 Revenue Reaches $15.002 Billion
AbbVie reported first-quarter 2026 net revenue of $15.002 billion, up 12.4 percent on a reported basis.
2026Twilio
Growth Re-accelerates
Twilio reported Q2 2026 revenue of $1.50 billion, up 22%, and raised its 2026 revenue growth outlook to 18%-18.5%.
Acquisitions
AbbVie
- ImmunoGen, Inc.2024$10.1B
- Cerevel Therapeutics2024$8.7B
- Allergan plc2020$63B
- Pharmacyclics, Inc.2015$21B
Questions about AbbVie vs Twilio
Who is the CEO of AbbVie Inc. and Twilio Inc.?
AbbVie Inc. is led by Robert A. Michael and Twilio Inc. is led by Khozema Shipchandler. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was AbbVie Inc. founded vs Twilio Inc.?
Twilio Inc. was founded in 2008 — 5 years before AbbVie Inc., which was founded in 2013. Twilio Inc.'s longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger AbbVie Inc..
How many employees does AbbVie Inc. have compared to Twilio Inc.?
AbbVie Inc. employs approximately 57,000 people, while Twilio Inc. employs approximately 5,492. AbbVie Inc. has the larger workforce at 57,000 employees, compared to Twilio Inc.'s 5,492. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are AbbVie Inc. and Twilio Inc. headquartered?
Both AbbVie Inc. and Twilio Inc. are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded AbbVie Inc. and Twilio Inc.?
AbbVie Inc. was founded by Abbott Laboratories (spin-off origin). Twilio Inc. was founded by Jeff Lawson, John Wolthuis, Evan Cooke.
Which company has a longer operating history — AbbVie Inc. or Twilio Inc.?
Twilio Inc. has been operating for approximately 18 years, making it the more established of the two companies. AbbVie Inc. has been in operation for around 13 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the AbbVie vs Twilio overview